The biotechnology company Novavax now plans to apply for emergency use authorization of its Covid-19 vaccine in the US in the third quarter of this year, CEO Stanley Erck told CNN in a phone interview on Monday.
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon